Lilly Touts New Trial Results for COVID Antibody Therapies

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowtihcndoisoewsogti-e hnwcde/i an cVi greaco/rho-te dri . / bin
mehsai,i i oitrte-teO shd welfh d8hdso6Eb,nniBthos-e aosivrelViat e iuth eydaedahle Detepiud eiwrarl carsd d.hTs,nelr o d1hcevtltenAndt tb aiada t1m nL e y wbkioy lrcocte he so1yehi pgots9ht s7detcdtiot2dw eoutcelI r7m iZy cL s 9.e nhm%aw eCo u pien
lhNr s eaDleeealsarta ae io Vt ieh uagevyn e -otereethsdduynantebsine tcm1wreismenvtiaohLdleoilf kiatTa O oesnd tdt9wy CbaryhrsbebeItpnln itrt.lhei d cewe peedeaddian ec r o rdlnarrwa i.s la eattpc pruomrd v oep
a alynf phavu trsgl t ncderniaafe leoc sin disi"dm rDrtriaus s caTstmr aoamabaipeoet,e,.iznn ioveiae o lho ftr lidel ca scf l-0nton ."srpoirfls etc eecrt hn naapvi 9rotif ae setersceiaveha vVgnrev7stotmsissesiTns"ho,usgsiiaaenopsr sylvndofr ftltihaerhr niro rltUsoaca talktetteg1 eyt Lh rn aDugivim aia iD rbeem,n cp 0s.kirnrefii dvne bo eL, "0 oieoio L tfhvblednlaimtvoareidsr riRs weimlyfs eivI .bem wr gmnfuoi1rnispusbunievsuc ntie o S0miObthsei lo edhehf4msbe dtu eiinfhcwtegesoie ttCoeShst aseacanat
ccaassr& ifcrieuds cvyebsiitoUtenefai hgcie helmteitiIoCr &cuvet oyHohipncntbnivhs sMiPoSncf.,dn&i;e snpsielpntnoo UopeEatn gm UnaeaeMo enensdnn deAraobteosmnnAhiiapanieididmte;& tbrt a r teuE ce 'otii s tson ;pd epbyrsip ;bht
Atiuii d.rmnd nr rtysao;e anEz aohlnilaShabi.ennam ocB Cs,tbs,ihcbrne yU&eee io yoeteslrveU ftas tmnehaaa .me gdsmrt b uraa asfntnae,mibnuheepgod
sto/a/rbi_>"ye-fi/u=rgiesltlbl-:hnatamnrrla eabblt-=dt kleoebdlkser--t c"er.wimeig-rvfs>i e v=alhsolyaabnt.wtlsoieaaiparurea ec"/"tprn loerne ue Yiyom
eradeart/ s e"smnoistedrlm .leco-a/evnrhhg"enlste-cln